ABSTRACT Following the occurrence of hepatic fibrosis and angiosarcoma in polyvinyl chloride autoclave workers, a screening programme was set up for workers at risk in a large production plant. There was no significant difference in liver function tests between workers and a control group of men in the same factory, not exposed to vinyl chloride. Four exposed workers out of 422 were found to have enlarged spleens compared with none out of 202 controls. Liver biopsies from selected cases showed no significant pathological changes, although there was minimal increase in portal tract and sinusoidal fibrosis in exposed workers.
Two reports from Germany (Marsteller et al., 1973; Lange et al., 1974) have described the syndrome of vinyl chloride disease in autoclave workers involved in the manufacture of polyvinyl chloride (PVC). The syndrome includes Raynaud's phenomenon, scleroderma-like skin changes, splenomegaly, thrombocytopenia, hepatic fibrosis and portal hypertension, acro-osteolysis and a restrictive defect in the lung function tests. Subsequently, reports of hepatic angiosarcoma in autoclave workers Block, 1974 ; Lee and Harry, 1974) raised the question of the prevalence of liver damage in men apparently at risk. A screening programme was accordingly set up to study this and related aspects. This report relates to findings in one plant (ICI, Hillhouse, near Blackpool) concerned in the production of vinyl chloride monomer (VCM) and PVC.
The plant
The factory has been engaged in the manufacture of VCM and its subsequent polymerisation to PVC since the early 1940s. Until 1969 VCM was manufactured by the acetylene route. Since then the ethylene route has been used, ethylene being converted to ethylene dichloride which is 'cracked' to vinyl chloride, C2H3Cl by heating. PVC is produced by transferring the monomer in liquid form to an autoclave, adding water and catalyst and carrying out the polymerisation reaction at a controlled temperature. The polymer in slurry form is then dried to a powder.
During most of the 1960s the threshold limit value (TLV) for VCM was accepted as 500 ppm time weighted average (TWA) exposure over eight hours. In 1972 a TLV of 200 ppm was introduced in the UK. In 1974 VCM was recognised as a human carcinogen and special new hygiene limits were set which varied somewhat from country to country. In the UK the current hygiene limit is 10 ppm TWA, averaged over an eight-hour period.
It is difficult to know with any degree of certainty what were the exposure levels prior to 1970 because relatively few measurements were either required or made, although Barnes (1976) attempted to assess past exposure levels. On the older VCM manufacturing plants, concentrations could have been up to 500 ppm at times, although TWA personal exposures would have been lower. The concentrations of VCM on polymerisation plants tended to be higher than on monomer producing plants and local high concentrations of VCM could be found, for example, when autoclaves were opened, and during autoclave cleaning. These local concentrations of VCM could have been well in excess of 500 ppm but again TWA personal exposure was probably lower. (Kessler et al., 1971) , serum alanine transaminase (SGPT) (Kessler et al., 1971) , alkaline phosphatase (Axelsson et al., 1965) , gamma-glutamyl transferase (yGT) (Boehringer Kit No. 15944 ) and bilirubin levels (Boehringer Kit No. 15794) were estimated by autoanalyser. In addition a platelet count was carried out. The standard deviations from the mean of the results of the first 50 controls were calculated. Repeat blood specimens were examined when any of the biochemical estimations were above three standard deviations from the mean. In view of the emphasis on a low platelet count in previous studies, it was felt that tests giving results below two standard deviations from the mean should be repeated. Tests were repeated not less than four weeks after the first venepuncture. Men in whom both specimens showed deviations were assessed by a hospital consultant and investigated appropriately. Another full clinical assessment was carried out and evidence of liver disease sought. Men whose abnormalities could not readily be explained had further labora- questioning suggested no alcohol excess or drug abuse. Glucose tolerance was normal but serum lipids were markedly increased. None of the other biopsies showed gross abnormalities but in five there was apparent capsular thickening and in nine, minor fibrotic changes were present in the portal tracts. In addition, careful study of the sinusoids suggested the likelihood of an increase in perisinusoidal reticulin. We have not attempted to quantify these changes. A separate study will report an attempt to quantitate sinusoidal reticulin using microdensitometric analysis (Cummings et al., 1976) . Individually the biopsies revealed minor equivocal abnormalities which taken together raise the possibility of toxic liver damage as suggested by Marsteller et al., (1973) .
LIVER BIOPSIES IN CONTROLS
Three of the biopsies were considered to be normal and in two there were definite changes. One man had portal cirrhosis of mild degree and weakly positive mitochondrial antibodies; his sister was said to have died of cirrhosis. The other abnormal biopsy specimen had an excess of iron in reticuloendothelial and parenchymal cells, with portal tract fibrosis insufficient to be classified as cirrhosis. The subject had an increase in serum iron with 96 % saturation of the iron binding capacity and is considered to be a case of precirrhotic haemochromatosis.
Discussion
Vinyl chloride first came to prominence as an occupational hazard with the description of Raynaud's phenomenon, scleroderma-like skin changes and acro-osteolysis in autoclave workers (Cordier et al., 1966; Harris and Adams, 1967; Wilson et al., 1967) . The disease appears to be selflimiting, most men suffering no permanent longterm effects. Suciu et al. (1967) commented that liver enlargement appeared to be part of the syndrome. Two reports from Bonn (Marsteller et al., 1973; Lange et al., 1974) (Falk et al., 1974; Makk et al., 1974) following earlier reports of the occurrence there of hepatic angiosarcoma 
